Received May 25, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Feeling arthritic; Suspected Vaccination failure; had a light case about a month ago; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. In APR-2026, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected Vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: had a light case about a month ago). On an unknown date, the patient experienced arthritis (Verbatim: Feeling arthritic). The outcome of the vaccination failure, shingles and arthritis were not reported. It was unknown if the reporter considered the vaccination failure, shingles and arthritis to be related to Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles and arthritis to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 17-MAY-2026 This case was reported by a patient via interactive digital media. The patient had a light case about a month ago. Took the medicines for it and kept it from getting worse but the patient did not seem to get the energy back and feeling arthritic. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting The batch number was not provided, and we are unable to contact the reporter; Sender's Comments: A case of Vaccination failure, unknown time after receiving Shingles vaccine. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.